Drug Substance Technologies, Amgen, Thousand Oaks, United States.
Drug Substance Technologies, Amgen, Thousand Oaks, United States.
J Biotechnol. 2019 Oct 10;304:70-77. doi: 10.1016/j.jbiotec.2019.08.001. Epub 2019 Aug 2.
Secreted recombinant proteins can aggregate during cell culture. We studied a poorly-behaved bispecific scaffold that increasingly aggregated (up to 62% high molecular weight species, HMW) as a function of culture time in a fed-batch and intensified cell culture processes. We identified that protein aggregates increased with accumulated protein concentration inside the bioreactor. Furthermore, results indicated that a maximum product concentration was reached beyond which no additional soluble protein accumulated in culture even when doubling the integrated viable cell density with the intensified process, suggesting additional secreted protein was precipitating. To overcome this limitation and maintain the cell-specific productivity (q) in culture, we explored a perfusion process where recombinant protein was continuously removed from the bioreactor to maintain low product concentration and consequently, minimize protein aggregation. We studied different viable cell densities (VCDs) inside the bioreactor (one to five-fold) and found a corresponding two-fold modulation of monomer levels. In all VCD conditions, q was maintained. On the contrary, the previous intensified process showed an "apparent" 2.5-fold decrease in q at the end of culture because of the presumed limited protein solubility at higher concentrations. The combination of lower aggregate levels and constant q resulted in up to four to five-fold increase in recoverable product (i.e., monomer) with the improved perfusion process.
分泌型重组蛋白在细胞培养过程中可能会发生聚集。我们研究了一种行为不良的双特异性支架,它在分批补料和强化细胞培养过程中随着培养时间的增加而逐渐聚集(高达 62%的高分子量物种,HMW)。我们发现,随着生物反应器内蛋白质浓度的积累,蛋白质聚集物增加。此外,结果表明,当集成的活细胞密度通过强化过程加倍时,产物浓度达到最大值,不再有额外的可溶性蛋白积累,表明额外的分泌蛋白沉淀。为了克服这一限制并保持培养过程中的细胞特异性产率(q),我们探索了一种灌注过程,其中重组蛋白连续从生物反应器中去除,以保持低产物浓度,从而最大限度地减少蛋白聚集。我们研究了生物反应器内不同的活细胞密度(VCD)(1 到 5 倍),发现单体水平相应地调节了两倍。在所有 VCD 条件下,q 得以维持。相反,之前的强化过程在培养结束时表现出“明显”的 q 值下降 2.5 倍,因为在较高浓度下假定蛋白质溶解度有限。较低的聚集水平和恒定的 q 值相结合,通过改进的灌注过程,使可回收产物(即单体)的产量增加了 4 到 5 倍。